NCT00037700View on ClinicalTrials.gov

Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Study Completion Date

December 31, 2002

Conditions
Rheumatoid Arthritis
Interventions
DRUG

anakinra

DRUG

pegsunercept

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY